Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Breaking News
Food truck hit by gunfire in Raleigh
Program
It's time for football! Tune to WRAL-TV to catch all the Week 1 highlights on Football Friday
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acadia Pharmaceutica
(NQ:
ACAD
)
15.94
+0.26 (+1.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acadia Pharmaceutica
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Why These 2 Biotech Stocks Made Big Moves Late Thursday
July 13, 2023
Markets kept powering higher on the day.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
July 13, 2023
Via
Benzinga
Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome
July 13, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Where ACADIA Pharmaceuticals Stands With Analysts
July 11, 2023
Via
Benzinga
11 Analysts Have This to Say About ACADIA Pharmaceuticals
June 14, 2023
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
June 14, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 29, 2023
Via
Benzinga
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Strategic Fit of ACP-101 Promises Future Revenue Growth for Acadia Pharmaceuticals: Analyst
June 14, 2023
Tuesday, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin), for hyperphagia (a false...
Via
Benzinga
Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome
June 13, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
ACADIA Pharmaceuticals's Return On Capital Employed Insights
May 23, 2023
Via
Benzinga
What 22 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
May 09, 2023
Via
Benzinga
ACADIA Pharmaceuticals's Earnings: A Preview
May 05, 2023
Via
Benzinga
Nature Medicine Publishes Results from Pivotal Phase 3 LAVENDER™ Study Evaluating DAYBUE™ (trofinetide) Efficacy and Safety in Patients with Rett Syndrome
June 08, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
3 Penny Stocks That Could Skyrocket in the Next 12 Months
June 07, 2023
Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors.
Via
InvestorPlace
Acadia Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
June 01, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Over $5M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying
May 25, 2023
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Analyst Ratings for ACADIA Pharmaceuticals
April 14, 2023
Via
Benzinga
ACADIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Acadia Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 24, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Records 52-Week High Tuesday Morning
May 23, 2023
Via
Investor Brand Network
Top 5 Health Care Stocks That Should Keep You Up At Night
May 23, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview
May 08, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
May 02, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2023
April 25, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Present DAYBUE™ (trofinetide) Clinical Data and Rett Syndrome Real World Evidence at the 2023 American Academy of Neurology (AAN) Annual Meeting
April 20, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Why ACADIA Pharmaceuticals (ACAD) Shares Are Trading Higher
April 17, 2023
ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) shares are trading higher by 6.23% to $19.11 Monday morning after the company announced the availability of DAYBUE for treatment of Rett syndrome. What Else?
Via
Benzinga
Acadia Pharmaceuticals Announces DAYBUE™ (trofinetide) is Now Available for the Treatment of Rett Syndrome
April 17, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Acadia Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.